Kane Biotech Inc V.KNE

New Press Release - Kane Biotech Announces Distribution Agreement with Razan Medical Trading for revyve(TM) Antimicrobial Wound Gel

Company’s First Distribution Agreement in Middle East WINNIPEG, Manitoba, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it has signed a three year distribution agreement with Razan Medical & Surgical Equipment...read article.

[francoisl13]

Interesting news, according to their website, Razan Medical & Surgical Equipment (RMT) is involved in the whole MENA region. The UAE ppulation is only 9,8 millions but the MENA region as a population of around 500 millions (according to the 'World Bank Group'... This region is considered a young, dynamic one with a rapid growth rate with most of the population having an intermediate

[francoisl13]

Clarification. Despite the fact that RMT are involved in the MENA region, the deal is only for UAE (as stated in the press release...I guess I got ahead of myself here)... so, approximately covering a population of 10M. GLTA!

[KevinOleary]

The marketing strategy is not clear, but no one should be selling their stock under $1, so we don't need to know the plan until all of the deals are done. Perhaps they are just doing deals with companies that have the best foothold in certain countries, so took RMT for their good toehold in UAE. Marketing companies can load their site with bs, so perhaps RMT just has a few salespeople in the

[MirrorWorldMan]

NR says the market is in the 100's.  Good enough for street Cred.. Our collaboration will bring forth an exceptional product to the UAE market which will benefit thousands of patients. We are thrilled about this partnership and look forward to a successful and impactful collaboratio

[KevinOleary]

Thousands at $20 or so each. UAE, with a very young demographic, is one of the tiniest markets in the world for this product.